Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 10/14/2011 1:51:20 PM : Outperform Start Price: $2.79 KERX Score: -45.64

biotech

Featured Broker Partners


Advertisement